Rabbit Polyclonal Fas antibody - conjugated to Biotin. Suitable for WB, sELISA and reacts with Recombinant fragment - Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human FAS aa 1-200.
View Alternative Names
CD95, APT1, FAS1, TNFRSF6, FAS, Tumor necrosis factor receptor superfamily member 6, Apo-1 antigen, Apoptosis-mediating surface antigen FAS, FASLG receptor
- sELISA
Supplier Data
Sandwich ELISA - Biotin Anti-Fas antibody (AB271240)
Human sFas Receptor was detected by sandwich ELISA (using 100μl/well) using a concentration of 0.25-1.0 μg/ml of ab271240. This antibody in conjunction with an appropriate capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant Human sFas Receptor protein.
- WB
Supplier Data
Western blot - Biotin Anti-Fas antibody (AB271240)
Western blot analysis of varying levels of Recombinant human Fas protein using ab271240 at 0.2 μg/ml.
Used in conjunction with compatible secondary reagents the detection limit for recombinant Fas is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
Lane ng/lane
1 Marker
2 250
3 125
4 62.5
5 31.25
6 15.625
7 7.8
8 3.9
9 1.95
10 0.975
11 0.4875
12 0.24
All lanes:
Western blot - Biotin Anti-Fas antibody (ab271240)
Predicted band size: 37 kDa
false
Reactivity data
Properties and storage information
Form
Reconstitution
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Molecular and cellular biochemistry 476:1751-1763 PubMed33433832
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com